Dealing with microscopic peritoneal metastases of epithelial ovarian cancer.A surgical challenge
Understanding biology and progression mechanisms of peritoneal metastases of epithelial ovarian cancer (EOC) is a cornerstone in the knowledge and the comprehensive management of the disease. Despite clinical remission after the association of complete cytoreductive surgery and platinum-based chemotherapy, peritoneal recurrence still occurs in 60% of patients.Eligible studies, published from 1980 to June 2016, were retrieved through ClinicalTrials.gov, MEDLINE, Cochrane databases and bibliography searches.
Source: Surgical Oncology - Category: Surgery Authors: Henri Aza ïs, Juan Pablo Estevez, Périne Foucher, Yohan Kerbage, Serge Mordon, Pierre Collinet Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Chemotherapy | Databases & Libraries | Epithelial Cancer | Ovarian Cancer | Ovaries | Peritoneal Cancer | Study | Surgery